- Canagliflozin +12014 | First Faculty of Medicine
- Fixed dose combination of canagliflozin and metformin2015 | Second Faculty of Medicine
- Canagliflozin reduces the risk of CKD progression in type 2 diabetes with nephropathy - main results of the CREDENCE study2019 | First Faculty of Medicine
- Canagliflozin: clinical significance of simultaneous balanced influencing of SGLT2 and SGLT12015 | Second Faculty of Medicine
- The renoprotective effects of canagliflozin demonstrated in the CREDENCE study cannot yet be considered as an effect of the whole class of SGLT2 inhibitors2020 | Second Faculty of Medicine
- Souvislosti mezi léčbou canagliflozinem a rizikem amputací v programu CANVAS2020 | Second Faculty of Medicine
- Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes2016 | Second Faculty of Medicine
- Canagliflozin 300 mg v současné paletě antidiabetik2020 | Third Faculty of Medicine
- Alternative method for canagliflozin oxidation analysis using an electrochemical flow cell - Comparative study2022 | Faculty of Science
- Canagliflozin: trochu jiný SGLT2 inhibitor2019 | Second Faculty of Medicine
- Canagliflozin oxidation study using electrochemical flow cell and comparison with hydrogen peroxide oxidation2020 | Faculty of Science
- Studie CANVAS: kardiovaskulární a renální efekty canagliflozinu2017 | First Faculty of Medicine
- Výsledky studie CREDENCE: Canagliflozin prokázal snížení rizika selhání ledvin u diabetiků 2. typu s nefropatií2019 | Third Faculty of Medicine
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 | Second Faculty of Medicine
- Léčba canagliflozinem snižuje riziko progrese renální insuficience a selhání ledvin u diabetiků 2. typu s nefropatií - výsledky studie CREDENCE2019 | Third Faculty of Medicine
- Efekt inhibitorů sodíko-glukózového kotransportéru-2 na výsledek 24hodinového monitorování krevního tlaku: systematický přehled a metaanalýza2019 | First Faculty of Medicine
- Tři schválené indikace jedné molekuly: dapagliflozin2023 | Faculty of Medicine in Hradec Králové
- Proč volit po metforminu gliflozin?2019 | First Faculty of Medicine
- CVD_REAL: The Real Benefit of Gliglozins for the Treatment of Type 2 Diabetes in Common Clinical Practice2018 | Faculty of Medicine in Hradec Králové
- Additional options in diabetes treatment - gliflozins2014 | Faculty of Medicine in Hradec Králové
- SGLT2 inhibitors in T2D and associated comorbidities differentiating within the class2019 | First Faculty of Medicine
- Gliflozins: already checked choice for type 2 diabetics2018 | First Faculty of Medicine
- Sodium glucose co-transporter-2 inhibitors in heart failure: beyond glycaemic control. The Position Paper of the Heart Failure Association of the European Society of Cardiology - summary of the document prepared by CKS2020 | First Faculty of Medicine
- Glifloziny: současnost a budoucnost2018 | First Faculty of Medicine
- Fournier's gangrene and gliflozins in therapy of diabetes mellitus2019 | Second Faculty of Medicine, Third Faculty of Medicine